novel coronavirus pneumonia (COVID-19)
Conditions
Interventions
Experimental group:qingjin Huashi Granules
Sponsors
Shenzhen the 3rd People's Hospital
Eligibility
Sex/Gender
All
Age
12 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Age from 12 to 70, regardless of gender. Those who meet the diagnostic criteria of mild or common type of clinical pneumonia; (2) No heat or low heat (T<38.5°C); (3) Novel coronavirus positive, and the virus sequencing result is Omicron strain; (4) Consent to sign a written informed consent letter before the study begins (for subjects without behavioral capacity, if the researcher thinks it is in their own interests for them to participate in the study, the informed consent should be signed by their legal guardian and explained in the original medical records and other relevant documents).
Exclusion criteria
Exclusion criteria: (1) Patients with severe non-infectious pulmonary underlying diseases, including pulmonary tumor, pulmonary edema, atelectasis, pulmonary embolism, pulmonary eosinophilic infiltration and pulmonary vasculitis; (2) Severe liver and kidney dysfunction: 1) ALT and AST more than 10 times the upper limit of normal value, 2) serum creatinine more than 1.5 times the upper limit of normal value, 3) total bilirubin more than 2 times the upper limit of normal value; (3) patients with biliary obstruction; (4) Pregnant women (positive urine or serum pregnancy test) or lactating women; (5) Subjects considered unsuitable for inclusion in this study by other researchers, or any conditions that may increase subjects' risk or interfere with the clinical trial as considered by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood sedimentation;Carbon dioxide partial pressure;Serum cytokine;Renal function;C-reactive protein;Myocardial enzyme;Blood sugar;Calcitonin original;T lymphocyte subsets;Liver function;Blood coagulation function;Routine blood; | — |
Countries
China
Contacts
Public ContactLu Hongzhou
Outcome results
None listed